Unicycive Therapeutics (UNCY) PT Lowered to $3 at Benchmark
Tweet
Share
E-mailGet Alerts UNCY Hot Sheet
Price: $5.63 +3.30%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Benchmark analyst Brice Jackson lowered the price target on Unicycive Therapeutics (NASDAQ: UNCY) to $3.00 (from $13.00) while maintaining a Speculative Buy rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Rockwell Automation (ROK) PT Lowered to $490 at DA Davidson
- Netease Inc. (9999:HK) (NTES) PT Lowered to HK$226 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
